HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

p38 MAPK regulates ischemia-reperfusion-induced recruitment of leukocytes in the colon.

AbstractBACKGROUND:
Our objective was to examine the role of p38 mitogen-activated protein kinase (MAPK) in ischemia-reperfusion (I/R)-induced recruitment or leukocytes in the colon.
METHODS:
C57/Bl6 mice were subjected to 30 minutes of ischemia by clamping the superior mesenteric artery followed by 2 hours of reperfusion. Animals were pretreated with the selective p38 MAPK inhibitors SB 239063 and SKF 86002 before induction of I/R. Leukocyte-endothelium interactions were quantified by use of intravital fluorescence microscopy. Additionally, the role of p38 MAPK in mast cell-generated tumor necrosis factor-alpha (TNF-alpha) as well as neutrophil adhesion and P-selectin expression were examined in vitro.
RESULTS:
SB 239063 and SKF 86002 decreased both I/R-provoked leukocyte rolling and adhesion by > 75%. Inhibition of p38 MAPK decreased dose-dependently the mast cell generated TNF-alpha production as well as TNF-alpha-induced expression of P-selectin and neutrophil adhesion on endothelial cells.
CONCLUSION:
We conclude that p38 MAPK regulates leukocyte rolling and adhesion in colonic I/R. Moreover, inhibition of p38 MAPK activity decreases formation of TNF-alpha and P-selectin-dependent leukocyte attachment to activated endothelial cells. Thus, our findings suggest that interference with the p38 MAPK signaling pathway could be an effective strategy to protect against I/R-induced inflammation in the colon.
AuthorsStefan Santén, Andrada Mihaescu, Matthias W Laschke, Michael D Menger, Yousheng Wang, Bengt Jeppsson, Henrik Thorlacius
JournalSurgery (Surgery) Vol. 145 Issue 3 Pg. 303-12 (Mar 2009) ISSN: 1532-7361 [Electronic] United States
PMID19231583 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Enzyme Inhibitors
  • Imidazoles
  • P-Selectin
  • Pyrimidines
  • Thiazoles
  • Tumor Necrosis Factor-alpha
  • 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole
  • p38 Mitogen-Activated Protein Kinases
  • SB 239063
Topics
  • Animals
  • Cell Adhesion (physiology)
  • Colitis (metabolism, pathology)
  • Colon (metabolism, pathology)
  • Dose-Response Relationship, Drug
  • Endothelial Cells (metabolism, pathology)
  • Enzyme Inhibitors (pharmacology)
  • Imidazoles (pharmacology)
  • Leukocytes (pathology)
  • Mast Cells (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • P-Selectin (metabolism)
  • Pyrimidines (pharmacology)
  • Reperfusion Injury (metabolism, pathology)
  • Signal Transduction (physiology)
  • Thiazoles (pharmacology)
  • Tumor Necrosis Factor-alpha (metabolism)
  • p38 Mitogen-Activated Protein Kinases (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: